Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound sophora flavescens injection for cancer pain
CTR20170214Phase 3Active
- Sponsor
- Shanxi Zhendong Pharmaceutical Co., Ltd.
- Start
- Mar 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of compound kushen injection in cancer pain, bronchial carcinoma, breast cancer, gastrointestinal cancer, liver cancer, sponsored by Shanxi Zhendong Pharmaceutical Co., Ltd.. Started Mar 2020; status: active.
02
Drugs
compound kushen injection
03
Conditions
cancer painbronchial carcinomabreast cancergastrointestinal cancerliver cancer
Beyond the preview
Go deeper on CTR20170214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170214.